These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 22869412)

  • 1. Prevalence of human papillomavirus infection in young women receiving the first quadrivalent vaccine dose.
    Widdice LE; Brown DR; Bernstein DI; Ding L; Patel D; Shew M; Fortenberry JD; Kahn JA
    Arch Pediatr Adolesc Med; 2012 Aug; 166(8):774-6. PubMed ID: 22869412
    [No Abstract]   [Full Text] [Related]  

  • 2. Prevalence of Human Papillomavirus Infection by Number of Vaccine Doses Among US Women.
    Sonawane K; Nyitray AG; Nemutlu GS; Swartz MD; Chhatwal J; Deshmukh AA
    JAMA Netw Open; 2019 Dec; 2(12):e1918571. PubMed ID: 31880792
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The efficacy and safety of the quadrivalent human papillomavirus 6/11/16/18 vaccine gardasil.
    Haupt RM; Sings HL
    J Adolesc Health; 2011 Nov; 49(5):467-75. PubMed ID: 22018560
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Human papillomavirus vaccines: an update for gynecologists.
    Ault KA
    Clin Obstet Gynecol; 2008 Sep; 51(3):527-32. PubMed ID: 18677145
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Quadrivalent human papillomavirus vaccination and trends in genital warts in Australia: analysis of national sentinel surveillance data.
    Donovan B; Franklin N; Guy R; Grulich AE; Regan DG; Ali H; Wand H; Fairley CK
    Lancet Infect Dis; 2011 Jan; 11(1):39-44. PubMed ID: 21067976
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Human papillomavirus prevalence in Canberra high school students: significance for vaccination strategies and adolescent health.
    Skinner SR; Kang M
    Sex Health; 2006 Dec; 3(4):299-300. PubMed ID: 17112445
    [No Abstract]   [Full Text] [Related]  

  • 7. Quadrivalent Human Papillomavirus Vaccine: Recommendations of the Advisory Committee on Immunization Practices (ACIP).
    Markowitz LE; Dunne EF; Saraiya M; Lawson HW; Chesson H; Unger ER; ;
    MMWR Recomm Rep; 2007 Mar; 56(RR-2):1-24. PubMed ID: 17380109
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prevalence and risk factors for HPV in HIV-positive young women receiving their first HPV vaccination.
    Kahn JA; Burk RD; Squires KE; Kapogiannis BG; Rudy B; Xu J; Gonin R; Liu N; Worrell C; Wilson CM
    J Acquir Immune Defic Syndr; 2012 Nov; 61(3):390-9. PubMed ID: 22820809
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Closing editorial: processes, opportunities and challenges after introduction of human papillomavirus vaccine.
    Brotherton JM; Fairley CK; Garland SM; Gertig D; Saville M
    Sex Health; 2010 Sep; 7(3):397-8. PubMed ID: 21058499
    [No Abstract]   [Full Text] [Related]  

  • 10. Bug breakfast in the bulletin: human papilloma virus.
    Wallace C; Weisberg E; McCaffery K
    N S W Public Health Bull; 2007; 18(5-6):97-8. PubMed ID: 17907356
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Survey among female university students on HPV infection epidemiology and prevention].
    Meleleo C; Sorbara D; Serino L; Di Rita R; Laudati F; Papa R; Renzi S; Senatore S; Cianti D; Zaratti L; Franco E
    Ig Sanita Pubbl; 2010; 66(4):563-8. PubMed ID: 21132046
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prevalence and incidence of HPV genital infection in women.
    Velicer C; Zhu X; Vuocolo S; Liaw KL; Saah A
    Sex Transm Dis; 2009 Nov; 36(11):696-703. PubMed ID: 19652630
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Promising control of genital warts: but is elimination possible?
    Lacey CJ; Garnett GP
    Lancet Infect Dis; 2011 Jan; 11(1):4-6. PubMed ID: 21183139
    [No Abstract]   [Full Text] [Related]  

  • 14. National survey of general practitioners' experience of delivering the National Human Papillomavirus Vaccination Program.
    Brotherton JM; Leask J; Jackson C; McCaffery K; Trevena LJ
    Sex Health; 2010 Sep; 7(3):291-8. PubMed ID: 20719217
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Epidemiology of Any and Vaccine-Type Anogenital Human Papillomavirus Among 13-26-Year-Old Young Men After HPV Vaccine Introduction.
    Chandler E; Ding L; Gorbach P; Franco EL; Brown DA; Widdice LE; Bernstein DI; Kahn JA
    J Adolesc Health; 2018 Jul; 63(1):43-49. PubMed ID: 30060856
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prevalence of human papillomavirus among STD clinic attenders in Jamaica: association of younger age and increased sexual activity.
    Figueroa JP; Ward E; Luthi TE; Vermund SH; Brathwaite AR; Burk RD
    Sex Transm Dis; 1995; 22(2):114-8. PubMed ID: 7624812
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Vaccination against human papillomaviridae. Expert correspondence no. 18 of 29 December 2006].
    Kommission Qualitätssicherung der Schweizerischen Gesellschaft für Gynäkologie und Geburtshilfe
    Gynakol Geburtshilfliche Rundsch; 2007; 47(2):101-2. PubMed ID: 17440273
    [No Abstract]   [Full Text] [Related]  

  • 18. What can surveillance of genital warts tell us?
    Fairley CK; Donovan B
    Sex Health; 2010 Sep; 7(3):325-7. PubMed ID: 20719222
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Low rates of free human papillomavirus vaccine uptake among young women.
    Moore GR; Crosby RA; Young A; Charnigo R
    Sex Health; 2010 Sep; 7(3):287-90. PubMed ID: 20719216
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Trends in Male and Female Genital Warts Among Adolescents in a Safety-Net Health Care System 2004-2013: Correlation With Introduction of Female and Male Human Papillomavirus Vaccination.
    Perkins RB; Legler A; Hanchate A
    Sex Transm Dis; 2015 Dec; 42(12):665-8. PubMed ID: 26562694
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.